ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,813.70
-0.07%
S&P ASX All Technology
3,284.90
-1.38%
Brent Oil
65.875
0.10%
US Dollar vs AUD
1.55678
-0.03%
Bitcoin
88,163.24
0.73%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Verve Therapeutics Inc (VERV) Share Price

Verve Therapeutics Inc

Verve Therapeutics Inc (VERV)

Verbund Ag
Verbund Ag
Verbund Ag
Verbund Ag
4.78
0.19
(4.14%)
Closed 22 April 6:00AM
Delayed by 15 minutes
4.781
0.001
(0.02%)
After Hours: 9:55AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
4.781
Bid
4.78
Offer
4.82
Volume
5,619,840
4.37 Day's Range 5.50
2.8647 52 Week Range 9.305
Market Cap
424.533M
Previous Close
4.59
Open
4.51
Last Trade
99
@
4.82
Last Trade Time
Financial Volume
US$ 27,899,459
VWAP
4.9645
Average Volume (3m)
2,540,443
Shares Outstanding
88,795,768
Dividend Yield
-
PE Ratio
-2.13
Earnings Per Share (EPS)
-2.24
Revenue
32.33M
Net Profit
-198.71M

About Verve Therapeutics Inc

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively... Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.vervetx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Verve Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VERV. The last closing price for Verve Therapeutics was US$4.59. Over the last year, Verve Therapeutics shares have traded in a share price range of US$ 2.8647 to US$ 9.305.

Verve Therapeutics currently has 88,795,768 shares in issue. The market capitalisation of Verve Therapeutics is US$407.57 million. Verve Therapeutics has a price to earnings ratio (PE ratio) of -2.13.

Ask ADVFN Intelligence (AI)

Verve Therapeutics (VERV) Options Flow Summary

VERV Options Flow

Overall Flow

Bullish

Net Premium

36k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

VERV Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
14 April 2025
VERV (4.14%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 April 2025
VERV (4.14%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 April 2025
VERV (4.14%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 April 2025
VERV (4.14%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 April 2025
VERV (4.14%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.69617.03794369654.0855.813.55165052164.49552883CS
4-0.859-15.23049645395.645.992.864750458804.30412169CS
12-3.079-39.17302798987.869.3052.864725404435.26502122CS
26-0.869-15.38053097355.659.3052.864720383555.57274258CS
52-1.969-29.17037037046.759.3052.864716905765.60445836CS
156-13.959-74.487726787618.74432.8647122885712.52602487CS
260-25.219-84.063333333330782.8647107662815.38100228CS

VERV - Frequently Asked Questions (FAQ)

What is the current Verve Therapeutics share price?
The current share price of Verve Therapeutics is US$ 4.781
How many Verve Therapeutics shares are in issue?
Verve Therapeutics has 88,795,768 shares in issue
What is the market cap of Verve Therapeutics?
The market capitalisation of Verve Therapeutics is USD 407.57M
What is the 1 year trading range for Verve Therapeutics share price?
Verve Therapeutics has traded in the range of US$ 2.8647 to US$ 9.305 during the past year
What is the PE ratio of Verve Therapeutics?
The price to earnings ratio of Verve Therapeutics is -2.13
What is the cash to sales ratio of Verve Therapeutics?
The cash to sales ratio of Verve Therapeutics is 13.1
What is the reporting currency for Verve Therapeutics?
Verve Therapeutics reports financial results in USD
What is the latest annual turnover for Verve Therapeutics?
The latest annual turnover of Verve Therapeutics is USD 32.33M
What is the latest annual profit for Verve Therapeutics?
The latest annual profit of Verve Therapeutics is USD -198.71M
What is the registered address of Verve Therapeutics?
The registered address for Verve Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Verve Therapeutics website address?
The website address for Verve Therapeutics is www.vervetx.com
Which industry sector does Verve Therapeutics operate in?
Verve Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UPXIUpexi Inc
US$ 9.83
(328.32%)
100.38M
SHFSSHF Holdings Inc
US$ 4.17
(87.00%)
43.5M
MLGOMicroAlgo Inc
US$ 11.84
(74.63%)
78.43M
MKDWMKDWELL Tech Inc
US$ 0.4027
(73.35%)
40.8M
MTENMingteng International Corporation Inc
US$ 6.24
(47.87%)
317.66k
AIEVThunder Power Holdings Inc
US$ 0.049999
(-63.02%)
6.25M
LXEHLixiang Education Holding Company Ltd
US$ 2.88
(-57.89%)
1.57M
AREBAmerican Rebel Holdings Inc
US$ 2.38
(-53.88%)
11.97M
SXTCChina SXT Pharmaceuticals Inc
US$ 1.029
(-52.36%)
1.66M
RTCBaijiayun Group Ltd
US$ 0.1862
(-49.68%)
7.75M
DMNDamon Inc
US$ 0.0041
(20.59%)
621.47M
NVDANVIDIA Corporation
US$ 96.91
(-4.51%)
288.68M
STSSSharps Technology Inc
US$ 0.0319
(-0.31%)
162.99M
RSLSReShape Lifesciences Inc
US$ 0.383
(23.67%)
152.04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 6.7742
(-11.68%)
151.31M

VERV Discussion

View Posts
Monksdream Monksdream 6 days ago
VERV up off a recent 52/week low
👍️0
glenn1919 glenn1919 7 days ago
VERV.................................................................................p/m
👍️0
glenn1919 glenn1919 1 week ago
VERV................................https://stockcharts.com/h-sc/ui?s=VERV&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
VERV 10Q due Monday 2/24
👍️0
Monksdream Monksdream 8 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 8 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 9 months ago
VERV 10Q due AUGUST5
👍️0
Monksdream Monksdream 10 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 10 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 11 months ago
VERV more new lows up ahead
👍️0
Monksdream Monksdream 11 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 12 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 12 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 12 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VERV new 52 lo
👍️0
Firestorm22 Firestorm22 1 year ago
uh oh
👍️0
Monksdream Monksdream 1 year ago
VERV over $10
👍️0
fink fink 1 year ago
Looking for an entry now
👍️0
Terpi Terpi 1 year ago
Could see another nice move here is the 50 day holds into close.
👍️0
Monksdream Monksdream 1 year ago
VERV morning rally
👍️0
TheFinalCD TheFinalCD 2 years ago
https://cathiesark.com/
👍️0
crudeoil24 crudeoil24 3 years ago
VERV IS A GREAT $$$$$ OPPORTUNITY.
👍️0
crudeoil24 crudeoil24 3 years ago
Verve Therapeutics started at outperform with $48 stock price target at BMO Capital
👍️0
crudeoil24 crudeoil24 3 years ago
Verve Therapeutics, Inc. is a genetic medicines company, developing an approach to the care of cardiovascular disease (CVD) transforming treatment from chronic management to single-course gene editing medicines. The Company’s initial two programs target PCSK9 and ANGPTL3, respectively, genes that regulate levels of blood lipids. Its lead product candidate, VERVE-101, is designed to permanently turn off the PCSK9 gene in the liver. Reduction of PCSK9 protein in the blood improves the ability of the liver to clear LDL-C from the blood. VERVE-101 utilizes LNP-mediated delivery to target the liver and base editing technology to make a single base change at a specific site in the PCSK9 gene in order to disrupt PCSK9 protein production. It is advancing VERVE-101 initially for the treatment of heterozygous familial hypercholesterolemia. Its second program is designed to permanently turn off the ANGPTL3 gene in the liver. ANGPTL3 is a key regulator of cholesterol and triglyceride metabolism.
👍️0

Your Recent History

NASDAQ
VERV
Verve Therapeutics
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads